Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Assistance Publique – Hôpitaux de Paris · Université Paris Cité · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,178
total citations
- FWCI
- 55.64
- Percentile
- 100%
- References
- 46
Citations per year
Authors
16- LBLila Bouadma
Assistance Publique – Hôpitaux de Paris, Université Paris Cité, Hôpital Bichat-Claude-Bernard
- CLCharles‐Édouard Luyt
Assistance Publique – Hôpitaux de Paris, Sorbonne Université
- FTFlorence Tubach
Hôpital Bichat-Claude-Bernard, Université Paris Cité, Assistance Publique – Hôpitaux de Paris
- CCChristophe Cracco
Assistance Publique – Hôpitaux de Paris, Sorbonne Université
- AAAntonio Alvarez
Centre Hospitalier Saint-Denis
Topics & keywords
Topics
Keywords
- Procalcitonin
- Medicine
- Antibiotics
- Internal medicine
- Randomized controlled trial
- Intensive care unit
- Intensive care medicine
- Sepsis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.